CEMTREX INC (CETX): Nasdaq/NYSE listing notice — Cemtrex gets Nasdaq extension to Aug 20, 2025 to regain minimum equity compliance

CEMTREX INC

Nasdaq granted extension until Aug 20, 2025 to meet minimum $2.5M stockholders' equity requirement.
Company's compliance plan cites Q1 2025 results: $20.6M revenue, $5M operating income through Feb 28.
Expects ~$4M warrant gain for Q2 ending Mar 31, 2025.
Plan includes potential debt-for-equity swaps on $11.9M notes and $15M Aegis Capital offering.
Failure to evidence compliance by Sep 30, 2025 Form 10-Q filing may trigger delisting.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.82

CEMTREX INC received a nasdaq compliance regained notice regarding late filing (rules 5550(b)(1)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: late filing
Rules: 5550(b)(1)

Exact text from the filing

August 20, 2025, the Company must complete the submitted plan and opt for one of the two following alternatives to evidence compliance with the Rule: Alternative 1 : The Company must furnish to the SEC and Nasdaq a publicly available report (e.g., a Form 8-K) including: 1. A disclosure of Staff’s deficiency letter and the specific deficiency(ies) cited; 2. A description of the completed transaction or event that enabled the Company to satisfy the stockholders’ equity requirement for continued listing; 3. An affirmative statement that, as of the date of the report, the Company believes it h

View on SEC.gov

Browse all listing & compliance notices →

CEMTREX INC filing history →

Source: SEC EDGAR

accession 0001641172-25-005782

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.